Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001746251-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-02-12	2026-02-10	COLL	Dreyer Scott	EVP, Chief Commercial Off	F - Tax	$46.75	-31.6K	143.4K	-18%	-$1.48M
M	2026-02-12	2026-02-10	COLL	Dreyer Scott	EVP, Chief Commercial Off	A - Grant	$0.00	+49.7K	122.6K	+68%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-10	F	D	21,615	$46.75	121,746	D	—	—	(F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
2	Common	Common Stock	2026-02-10	F	D	9,977	$46.75	143,361	D	—	—	(F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
3	Common	Common Stock	2026-02-10	A	A	30,702	$0.00	153,338	D	—	—	(F2) Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
4	Common	Common Stock	2026-02-10	A	A	19,023	$0.00	122,636	D	—	—	(F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.